Key statistics
On Wednesday, HUTCHMED (China) Ltd (H7T2:STU) closed at 2.62, 29.70% above the 52 week low of 2.02 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.56 |
---|---|
High | 2.62 |
Low | 2.56 |
Bid | 2.62 |
Offer | 2.94 |
Previous close | 2.56 |
Average volume | 0.00 |
---|---|
Shares outstanding | 872.11m |
Free float | 501.29m |
P/E (TTM) | 74.27 |
Market cap | 21.98bn HKD |
EPS (TTM) | 0.3393 HKD |
Data delayed at least 15 minutes, as of Jul 09 2025.
More ▼
- HUTCHMED to Announce 2025 Half-Year Results
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
More ▼